Article Title: Survey On Screening For Metabolic Syndrome Parameters For Patients On Antipsychotic Treatment In An Acute Adult Psychiatric Unit In England
Author(s): Feras A. Mustafa, Rizwana Jafry
Institute(s): Princess Marina Hospital, Upton, Northampton, England and School of Health, University of Northampton, Northampton, England.
Journal: Journal of Pakistan Psychiatric Society, 2009; 6(1): 44-45 SHORT COMMUNICATION
Correspondence Address: firstname.lastname@example.org.
Metabolic syndrome is a cluster of disorders comprising obesity, dyslipidaemias, glucose intolerance, insulin resistance and hypertension1. It helps identify individuals at high risk of both type 2 diabetes and cardiovascular disease (CVD)2.
SUBJECTS AND METHODS
Sample 40 patients admitted to acute adult psychiatric wards at Berrywood Hospital and receiving treatment with antipsychotic medications.
The data was collected on patients’ demographics (age, gender and ethnicity), current antipsychotic medication, baseline recording of weight, height and Body Mass Index (BMI), fasting and random blood glucose levels, Serum Triglycerides, Cholesterol and HDL-C.
The age range of the patient was from 18 to 73 years.
Gender distribution The total number of the patients in the sample was forty. Twenty three patients were male (57.5%) and seventeen female (43.5%). (Fig 1).
Ethnicity 36 (90%) patients were white, 1(2.5%) patient was of mixed heritage. 2(5%) patients were black and the ethnicity of 1 (2.5%) patient was not recorded. (Fig. 2).